CervoMed (CRVO) Intangibles (2010 - 2021)
CervoMed (CRVO) posted Intangibles of $8.6 million for Q2 2021, little changed sequentially from $8.6 million in Q1 2021, and little changed YoY from $8.6 million in Q2 2020.
CervoMed (CRVO) Intangibles (2010 - 2021) Analysis & Trends
CervoMed has reported Intangibles for 12 years, with the latest figure at $8.6 million in Q2 2021.
- Quarterly Intangibles changed 0.0% year-over-year to $8.6 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $8.6 million (changed 0.0% YoY) and the FY2020 annual result came in at $8.6 million, changed 0.0% from the prior year.
- Intangibles steadied at $8.6 million in Q2 2021 per CRVO's latest filing, from $8.6 million in the prior quarter.
- Over five years, Intangibles peaked at $8.6 million in Q1 2017 and troughed at $8.6 million in Q1 2017.
- A 5-year average of $8.6 million and a median of $8.6 million in 2017 frame the typical range for Intangibles.
- The widest YoY moves for Intangibles: up 0.0% in 2017, down 7.28% in 2017.
- Over 5 years, Intangibles stood at $8.6 million in 2017, then changed by 0.0% to $8.6 million in 2018, then changed by 0.0% to $8.6 million in 2019, then changed by 0.0% to $8.6 million in 2020, then changed by 0.0% to $8.6 million in 2021.
- According to Business Quant data, Intangibles over the past three periods registered $8.6 million, $8.6 million, and $8.6 million for Q2 2021, Q1 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 8.64 Mn |
| Mar 31, 2021 | 8.64 Mn |
| Dec 31, 2020 | 8.64 Mn |
| Sep 30, 2020 | 8.64 Mn |
| Jun 30, 2020 | 8.64 Mn |
| Mar 31, 2020 | 8.64 Mn |
| Dec 31, 2019 | 8.64 Mn |
| Sep 30, 2019 | 8.64 Mn |
| Jun 30, 2019 | 8.64 Mn |
| Mar 31, 2019 | 8.64 Mn |
| Dec 31, 2018 | 8.64 Mn |
| Sep 30, 2018 | 8.64 Mn |
| Jun 30, 2018 | 8.64 Mn |
| Mar 31, 2018 | 8.64 Mn |
| Dec 31, 2017 | 8.64 Mn |
| Sep 30, 2017 | 8.64 Mn |
| Jun 30, 2017 | 8.64 Mn |
| Mar 31, 2017 | 8.64 Mn |
| Dec 31, 2016 | 8.64 Mn |
| Jun 30, 2016 | 9.32 Mn |